“Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature”, Arch Ital Urol Androl, vol. 91, no. 4, pp. 205–210, Jan. 2020, doi: 10.4081/aiua.2019.4.205.